Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010 · cited 1×
“Most acute CV events, including myocardial infarction and stroke, are caused by rupture of an atherosclerotic plaque [15–17].”
BackgroundFalk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087481.55887.c9 · Cited by 2,668
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087480.94275.97 · Cited by 2,270
Pathophysiology of coronary artery disease
Libby, P., & Theroux, P. (2005) · Circulation · doi:10.1161/circulationaha.105.537878 · Cited by 1,965
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455 · cited 1×
“A growing body of literature, however, has described several side effects associated with GnRH agonist therapy that include a 10–50% increased risk of bone fractures, peripheral insulin sensitivity, coronary heart disease, myocardial infarction, and sudden cardiac death, in addition to adverse effects on body mass, ch…”
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer: A Randomized Trial
D’Amico, A. V., Chen, M.-H., Renshaw, A. A., Loffredo, M., & Kantoff, P. W. (2008) · JAMA · doi:10.1001/jama.299.3.289 · Cited by 690
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
Araujo, A. B., Dixon, J. M., Suarez, E. A., Murad, M. H., Guey, L. T., & Wittert, G. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1137 · Cited by 671
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
Saigal, C. S., Gore, J. L., Krupski, T. L., Hanley, J., Schonlau, M., & Litwin, M. S. (2007) · Cancer · doi:10.1002/cncr.22933 · Cited by 542
D'Amico, A. V., Denham, J. W., Crook, J., Chen, M.-H., Goldhaber, S. Z., Lamb, D. S., Joseph, D., Tai, K.-H., Malone, S., Ludgate, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3369 · Cited by 501 · cited 1×
“A growing body of literature, however, has described several side effects associated with GnRH agonist therapy that include a 10–50% increased risk of bone fractures, peripheral insulin sensitivity, coronary heart disease, myocardial infarction, and sudden cardiac death, in addition to adverse effects on body mass, ch…”
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
Corona, G., Rastrelli, G., Monami, M., Guay, A., Buvat, J., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0447 · Cited by 435 · cited 1×
“Previous studies have clearly established that low testosterone levels are associated with increased CV risk [11–14].”
Pathologic assessment of the vulnerable human coronary plaque
Kolodgie, F. D., Virmani, R., Burke, A. P., Farb, A., Weber, D. K., Kutys, R., Finn, A. V., & Gold, H. K. (2004) · Heart · doi:10.1136/hrt.2004.041798 · Cited by 414
Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., Milani, R. V., Sagalowsky, A. I., Smith, M. R., & Zakai, N. (2010) · Circulation · doi:10.1161/circulationaha.109.192695 · Cited by 383
Expression of Follicle-Stimulating Hormone Receptor in Tumor Blood Vessels
Radu, A., Pichon, C., Camparo, P., Antoine, M., Allory, Y., Couvelard, A., Fromont, G., Hai, M. T. V., & Ghinea, N. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001283 · Cited by 302
Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes
Falk, E. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90242-7 · Cited by 298
Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer
Pagliarulo, V., Bracarda, S., Eisenberger, M. A., Mottet, N., Schröder, F. H., Sternberg, C. N., & Studer, U. E. (2012) · European Urology · doi:10.1016/j.eururo.2011.08.026 · Cited by 266
Adaptive immunity in atherogenesis: new insights and therapeutic approaches
Lichtman, A. H., Binder, C. J., Tsimikas, S., & Witztum, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63108 · Cited by 198
Chen, H., Jeung, E., Stephenson, M. D., & Leung, P. C. K. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5440 · Cited by 147
Costanzo, S., Castelnuovo, A. F. D., Donati, M. B., Iacoviello, L., & de Gaetano, G. (2010) · Circulation · doi:10.1161/circulationaha.109.865840 · Cited by 112
Management of complications of androgen deprivation therapy in the older man
Mohile, S. G., Mustian, K. M., Bylow, K. A., Hall, W. J., & Dale, W. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.09.004 · Cited by 91
Smith, M. R., Klotz, L. H., Persson, B., Olesen, T. K., & Wilde, A. A. M. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.08.012 · Cited by 83
Self-citationSmith, M. R., Klotz, L. H., van der Meulen, E., Colli, E., & Tankó, L. B. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.07.035 · Cited by 66
Self-citationConteduca, V., Lorenzo, G. D., Tartarone, A., & Aieta, M. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.09.008 · Cited by 61
Bourke, L., Kirkbride, P., Hooper, R., Rosario, A. J., Chico, T., & Rosario, D. J. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.523 · Cited by 60
Tanrıverdi, F., González-Martínez, D., Hu, Y., Keleştimur, F., & Bouloux, P. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02904.x · Cited by 57
Gonadotropin-Releasing Hormone Alters the T Helper Cytokine Balance in the Pregnant Rat1
Dixit, V. D., Yang, H., Udhayakumar, V., & Sridaran, R. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.012211 · Cited by 38
Ginzburg, S., & Albertsen, P. C. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.05.005 · Cited by 7
Self-citation
Cited by
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Mohler, J. L., Antonarakis, E. S., Armstrong, A. J., D’Amico, A. V., Davis, B. J., Dorff, T., Eastham, J. A., Enke, C. A., Farrington, T. A., Higano, C. S., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0023 · Cited by 1,532
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
Nguyen, P. L., Alibhai, S. M. H., Basaria, S., D’Amico, A. V., Kantoff, P. W., Keating, N. L., Penson, D. F., Rosario, D. J., Tombal, B., & Smith, M. R. (2015) · European Urology · doi:10.1016/j.eururo.2014.07.010 · Cited by 831
Self-citationHormonal Therapy for Prostate Cancer
Desai, K., McManus, J. M., & Sharifi, N. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab002 · Cited by 447
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
Shore, N. D., Saad, F., Cookson, M. S., George, D. J., Saltzstein, D. R., Tutrone, R., Akaza, H., Bossi, A., van Veenhuyzen, D. F., Selby, B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004325 · Cited by 444
Self-citationAndrogen-targeted therapy in men with prostate cancer: evolving practice and future considerations
Crawford, E. D., Heidenreich, A., Lawrentschuk, N., Tombal, B., Pompeo, A. C. L., Mendoza-Valdes, A., Miller, K., Debruyne, F. M. J., & Klotz, L. (2019) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-018-0079-0 · Cited by 360
Self-citation
Metadata
- Authors
- Albertsen, P. C., Klotz, L., Tombal, B., Grady, J., Olesen, T. K., & Nilsson, J.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 65
- Issue
- 3
- Pages
- 565-573
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W2099037568
- Cited by
- 341
- References
- 33
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.